Cardiovascular and Intracranial Alterations Induced by Buprenorphine and Sevoflurane Association in Dogs
WSAVA 2002 Congress
*Newton Nunes, Márlis Langenegger de Rezende, Almir Pereira de Souza, Paulo Sérgio Patto dos Santos, Danielli Parrilha de Paula, Celina Tie Nishimori
*Universidade Estadual Paulista - FCAV - Jaboticabal, Via de acesso Prof. Paulo Donato Castellane s/n° - zona rural
Jaboticabal, São Paulo, SP BR
newton@fcav.unesp.br

OBJECTIVES

The aim of this study was to evaluate the possible cardiovascular and intracranial alterations caused by buprenorphine in dogs, during sevoflurane anesthesia.

MATERIALS

Eight adult healthy male and female mongrel dogs were used. The anesthetic induction was made using propofol (IV), and immediately after, the dogs were intubated and the tube was connected to a volatile anesthetic circuit, and sevoflurane was administrated at 1.5 MAC. During the experimental period, the dogs were maintained under controlled ventilation. After 15 minutes of anesthesia, the dogs received buprenorphine (0.02 mg/kg/IV). Intracranial pressure (ICP); cerebral perfusion pressure (CPP); heart rate (HR); systolic, diastolic and mean arterial blood pressure (SAP, DAP, and MAP, respectively); cardiac output (CO); central venous pressure (CVP) and pulmonary arterial pressure (PAP) were evaluated. The measurements were realized 20 minutes after induction (M1), 15 minutes after buprenorphine administration (M2); and at each 15 minutes after M2 (M3, M4 and M5). The numerical data were submitted to Tukey test (p<0.05).

RESULTS

The ICP remained constant during the study. There was an increase in the ICP after buprenorphine administration (M2), but it wasn't statistically significant. However, a reduction in the CPP after M2 was noted.

The cardiovascular values HR, SAP, DAP, MAP, CO, and PAP decreased after M2, and remained constant during all the experimental period. We didn't find significant alterations in the CVP values, but an increase was observed after buprenorphine administration.

CONCLUSION

The results allow us to conclude that buprenorphine didn't interfere in the intracranial pressure. However, the reduction of the arterial pressure caused by buprenorphine administration determined a reduction of the cerebral perfusion pressure in dogs anesthetized with sevoflurane.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Almir Pereira de Souza
Universidade Estadual Paulista - FCAV - Jaboticabal
Via de acesso Prof. Paulo Donato Castellane s/n° - zona rural
Jaboticabal, São Paulo/ SP 14884-900 BR

Celina Tie Nishimori
Universidade Estadual Paulista - FCAV - Jaboticabal
Via de acesso Prof. Paulo Donato Castellane s/n° - zona rural
Jaboticabal, São Paulo/ SP 14884-900 BR

Danielli Parrilha de Paula
Universidade Estadual Paulista - FCAV - Jaboticabal
Via de acceso prof, Paulo Donato Castellane s/n° - zona rural
Jaboticabal, São Paulo/ SP 14884-900 BR

Márlis Langenegger de Rezende
Universidade Estadual Paulista - FCAV - Jaboticabal
Via de acceso Prof. Paulo Donato Castellane s/n° - zona rural
Jaboticabal, SP 14884-900 BR

Newton Nunes
Universidade Estadual Paulista - FCAV - Jaboticabal
Via de acesso Prof. Paulo Donato Castellane s/n° - zona rural
Jaboticabal, São Paulo/ SP 14884-900 BR

Paulo Sergio Patto dos Santos
Universidade Estadual Paulista - FCAV - Jaboticabal
Via de acceso Prof. Paulo Donato Castellane s/n° - zona rural
Jaboticabal, SP 14884-900 BR


MAIN : : Buprenorphine and Sevoflurane
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27